Style | Citing Format |
---|---|
MLA | Sm Naghib Seyed MORTEZA, B Ahmadi BAHAR, Mr Mozafari M R. "Stimuli-Sensitive Chitosan-Based Nanosystems-Immobilized Nucleic Acids for Gene Therapy in Breast Cancer and Hepatocellular Carcinoma." Current Topics in Medicinal Chemistry, vol. 24, no. 17, 2024, pp. 1464-1489. |
APA | Sm Naghib Seyed MORTEZA, B Ahmadi BAHAR, Mr Mozafari M R (2024). Stimuli-Sensitive Chitosan-Based Nanosystems-Immobilized Nucleic Acids for Gene Therapy in Breast Cancer and Hepatocellular Carcinoma. Current Topics in Medicinal Chemistry, 24(17), 1464-1489. |
Chicago | Sm Naghib Seyed MORTEZA, B Ahmadi BAHAR, Mr Mozafari M R. "Stimuli-Sensitive Chitosan-Based Nanosystems-Immobilized Nucleic Acids for Gene Therapy in Breast Cancer and Hepatocellular Carcinoma." Current Topics in Medicinal Chemistry 24, no. 17 (2024): 1464-1489. |
Harvard | Sm Naghib Seyed MORTEZA, B Ahmadi BAHAR, Mr Mozafari M R (2024) 'Stimuli-Sensitive Chitosan-Based Nanosystems-Immobilized Nucleic Acids for Gene Therapy in Breast Cancer and Hepatocellular Carcinoma', Current Topics in Medicinal Chemistry, 24(17), pp. 1464-1489. |
Vancouver | Sm Naghib Seyed MORTEZA, B Ahmadi BAHAR, Mr Mozafari M R. Stimuli-Sensitive Chitosan-Based Nanosystems-Immobilized Nucleic Acids for Gene Therapy in Breast Cancer and Hepatocellular Carcinoma. Current Topics in Medicinal Chemistry. 2024;24(17):1464-1489. |
BibTex | @article{ author = {Sm Naghib Seyed MORTEZA and B Ahmadi BAHAR and Mr Mozafari M R}, title = {Stimuli-Sensitive Chitosan-Based Nanosystems-Immobilized Nucleic Acids for Gene Therapy in Breast Cancer and Hepatocellular Carcinoma}, journal = {Current Topics in Medicinal Chemistry}, volume = {24}, number = {17}, pages = {1464-1489}, year = {2024} } |
RIS | TY - JOUR AU - Sm Naghib Seyed MORTEZA AU - B Ahmadi BAHAR AU - Mr Mozafari M R TI - Stimuli-Sensitive Chitosan-Based Nanosystems-Immobilized Nucleic Acids for Gene Therapy in Breast Cancer and Hepatocellular Carcinoma JO - Current Topics in Medicinal Chemistry VL - 24 IS - 17 SP - 1464 EP - 1489 PY - 2024 ER - |